Live Feeds
● TRACKER Updated 2d ago Β· 102 sources tracked

US provides Ebola treatment for outbreak in Congo, bringing trials closer

The Ebola outbreak in the Democratic Republic of Congo continues to expand unchecked six months into the response, with government data recording more than 11,000 cases and nearly half of those infected dying. This current crisis represents the deadliest of Congo's 17 recorded outbreaks and stands on pace to exceed the historical death toll of the 2014 to 2016 West African epidemic. Public health organizations are currently working to advance clinical trials and treatment delivery across the affected regions.

πŸŽ™οΈ

Listen to Live Briefing

Real-time synthesized voice briefing Β· Live Feeds Desk

⏱ ~2 min
Speed:
RSS Source map (100)
⚑ Key Developments & Real-Time Context
Text size:
  • βœ“ More than 11,000 cases have been recorded in the current Congo Ebola outbreak.
  • βœ“ Nearly half of those infected in the outbreak have died, according to government data.
πŸ›‘οΈ Source Corroboration: 102 independent reporting domains (90% confidence) ⏱ Read time: ~2 min

What changed

Government data now records more than 11,000 total cases, reflecting an upward revision from earlier infection totals.

Live updates

  1. Congo Ebola Outbreak Escalates as Death Toll Climbs

    The Ebola outbreak in the Democratic Republic of Congo continues to expand unchecked six months into the response, with government data recording more than 11,000 cases and nearly half of those infected dying. This current crisis represents the deadliest of Congo's 17 recorded outbreaks and stands on pace to exceed the historical death toll of the 2014 to 2016 West African epidemic. Public health organizations are currently working to advance clinical trials and treatment delivery across the affected regions.

    Why it matters

    Outbreaks of this magnitude test the limits of international health interventions and regional infrastructure in central Africa. Delayed funding timelines and complex logistical barriers frequently hinder rapid responses to fast-moving viral pathogens. The scale of the current transmission rate places intense pressure on local health systems and global medical partners.

    What is confirmed

    • More than 11,000 cases have been recorded in the current Congo Ebola outbreak.
    • Nearly half of those infected in the outbreak have died, according to government data.

    What to watch next

    • Updates on the deployment and efficacy results of the Tumaini clinical trial candidates
    • Further government data releases regarding infection rates and geographic spread
    Sources used for this update (4)
    1. unblock.federalregister.gov β€” Federal Register :: Removal of Automatic Extensions for Certain Employment Authorization Documents
    2. www.dropsitenews.com β€” Egypt shuts down Mada Masr, convicts editor; Israelis vote as UN panel concludes genocide is ongoing; U.S. demands AI execs’ tes....
    3. ssir.org β€” Climate Resilience Will Not Be Built by Press Release (SSIR)
    4. www.pbs.org β€” Ebola outbreak remains out of control in Congo 6 months into response
    confidence 90%
  2. WHO adds two Bundibugyo Ebola vaccines to DRC Tumaini trial

    WHO expert groups recommend adding two experimental Ebola vaccine candidates to the Tumaini clinical trial in the Democratic Republic of Congo. The candidates are Oxford's ChAdOx1 BDBV and Moderna's mRNA-1469, according to the Latin Times. This is the first active-outbreak efficacy study of vaccines designed specifically against Bundibugyo virus, which drives the current outbreak. UN News reports the outbreak has spread across eight eastern and northeastern provinces, with more than 10,500 infections and about half of those patients dying. WHO is working with DRC authorities and other UN agencies on prevention, diagnosis, treatment and community awareness.

    Why it matters

    The Tumaini trial is expanding while the DRC faces a fast-growing outbreak of Bundibugyo Ebola, a species for which vaccine candidates had not previously been tested during an active outbreak. WHO's recommendation moves the two candidates into a trial involving contacts of patients, so efficacy evidence will come from the outbreak itself rather than only from earlier laboratory or stage studies. The outbreak has persisted for nearly six months since its declaration, and the scale of reported infections and deaths shows why the trial expansion matters.

    What is confirmed

    • WHO expert groups convened by the World Health Organization recommended adding two new Ebola vaccine candidates to the ongoing Tumaini clinical trial in the Democratic Republic of Congo.
    • The two candidates are Oxford's ChAdOx1 BDBV and Moderna's mRNA-1469.
    • The recommendation marks the first time vaccines specifically designed to protect against Bundibugyo virus will be evaluated during an active Ebola outbreak.
    • The Ebola outbreak in the Democratic Republic of Congo has spread to eight provinces in the east and northeast, infecting more than 10,500 people and killing about half of them.
    • WHO is working with DRC authorities and other UN agencies on prevention, diagnosis, treatment and community awareness.
    • The Tumaini trial is the first efficacy study targeting the Bundibugyo strain.

    Still unconfirmed

    • An Ebola vaccine received WHO approval to enter Phase II/III, according to Gate Blog's preview of Moderna's third-quarter earnings.

    What to watch next

    • Enrollment and dosing results from the Tumaini trial as the two Bundibugyo vaccine candidates are tested among contacts of patients.
    • Further WHO or DRC guidance on whether the recommended candidates will move beyond trial use into wider deployment during the outbreak.
    • Updated case and death totals from WHO and DRC health authorities as the outbreak expands beyond eight provinces.
    Sources used for this update (14)
    1. www.who.int β€” World Health Organization (WHO)
    2. www.cdc.gov β€” People with Certain Medical Conditions and COVID-19 Risk Factors | Covid | CDC
    3. transcripts.cnn.com β€” Global Markets in the Red Following A.I. Slowdown Fears Following Midterm Outcome in the U.S.; Paraguayan President Resigns Follow....
    4. www.cidrap.umn.edu β€” As Ebola cases near 10,700, WHO recommends adding 2 Bundibugyo vaccines to clinical trial | CIDRAP
    5. www.gate.com β€” Moderna (MRNA) Q3 Earnings Preview: Shares Rally 13% β€” Can Two Key R&D Developments Support Its Valuation? | Gate Blog
    6. news.un.org β€” Two new Ebola vaccines to join DR Congo clinical trial - UN News
    7. www.techtimes.com β€” First Bundibugyo Ebola Vaccines Enter Active-Outbreak ...
    8. www.who.int β€” Two new candidate vaccines to join Ebola trial as treatment ...
    9. www.gavi.org β€” Can two new vaccines help turn the tide against Bundibugyo Ebola?
    10. news.un.org β€” DR Congo Ebola outbreak: Vaccine trial brings new hope
    11. africamonitoring.com β€” WHO Recommends Two Vaccine Candidates For DRC Ebola Trial
    12. www.latintimes.com β€” WHO Backs 2 New Ebola Vaccines for Trial. 5,300+ Dead ...
    confidence 90%
  3. WHO expands Ebola vaccine trials in Congo to target Bundibugyo virus

    The World Health Organization has recommended adding two new vaccine candidates to the ongoing Tumaini clinical trials in the Democratic Republic of Congo. These candidates target the Bundibugyo virus, which has caused more than 5,300 deaths. The WHO aims for these trials to help control the current outbreak. This expansion follows previous US provision of treatment and an existing WHO vaccine trial in the region.

    Why it matters

    The Bundibugyo virus is the driver of the current 2026 outbreak in Congo. Effective vaccination is critical as the virus has already killed thousands. Response efforts face challenges from historical distrust and recent funding shifts.

    What is confirmed

    • The Bundibugyo virus has killed more than 5,300 people in the DR Congo.
    • WHO expert groups recommended adding two new Ebola vaccine candidates to the Tumaini clinical trials.

    Still unconfirmed

    • U.S. aid cuts weakened the response to the 2026 Bundibugyo Ebola outbreak.
    • Colonial roots contributed to distrust during the Ebola response.

    What to watch next

    • Results from the Tumaini clinical trials regarding the two new vaccine candidates
    • Updated death tolls from the Bundibugyo virus outbreak in Congo
    Sources used for this update (5)
    1. jen.jiji.com β€” Kazakhstan and Uzbekistan agree to increase weekly flights
    2. www.aljazeera.com β€” WHO approves trials for two new Ebola vaccines - Al Jazeera
    3. historianspeaks.org β€” Ebola in Eastern Congo and the Retreat of U.S. Aid ...
    4. www.miragenews.com β€” Two New Vaccine Candidates Join Ebola Trial as Research ...
    5. www.channelafrica.co.za β€” WHO hopes DRC vaccine trials will help tackle Bundibugyo ...
    confidence 90%
  4. US provides Ebola treatment for Congo outbreak, boosting trial prospects

    The US has provided Ebola treatment for the outbreak in Congo, bringing clinical trials closer. Over 4,800 deaths have been reported since the outbreak began. The World Health Organization has started a clinical trial of an Ebola vaccine in Congo. African health experts are urging immediate action over new Ebola cases in Kenya and Nigeria.

    Why it matters

    The Ebola outbreak in Congo has resulted in a significant number of deaths, prompting urgent action from health organizations. The World Health Organization and other health experts are working to contain the outbreak and prevent further spread. The clinical trials of Ebola vaccines aim to find effective treatments for the disease.

    What is confirmed

    • The Ebola outbreak in Congo has resulted in over 4,800 deaths.
    • The World Health Organization has begun a clinical trial of an Ebola vaccine in Congo.
    • The US has provided Ebola treatment for the outbreak in Congo.
    • IAVI, a biomedical research organization, received $36 million under a US government contract to advance development of its single-dose vaccine candidate against the Bundibugyo strain.

    Still unconfirmed

    • New Ebola cases have been reported in Kenya and Nigeria.

    What to watch next

    • Further updates on the clinical trials of Ebola vaccines in Congo
    • Development of effective treatments for the Bundibugyo strain of Ebola
    • Response to new Ebola cases in Kenya and Nigeria
    Sources used for this update (7)
    1. www.scientificamerican.com β€” Scientific American
    2. transcripts.cnn.com β€” Nobel Peace Laureate Murad Discusses Life, Dreams Before ISIS; Ebola Cases Across Democratic Republic of Congo Hit 10,000 Plus; Fl....
    3. www.medicaldaily.com β€” Ebola Vaccine Trial Begins in Congo as Bundibugyo Outbreak ...
    4. www.upr.org β€” Ebola vaccine trials begin in DRC | Utah Public Radio
    5. www.emjreviews.com β€” Ebola Vaccine Trial Begins as Congo Outbreak Deaths Rise
    6. kfgo.com β€” Research organization IAVI receives US funding for Ebola ...
    7. en.sedaily.com β€” SK Bioscience Joins U.S.-Backed Bundibugyo Ebola Vaccine ...
    confidence 85%
  5. US provides Ebola treatment to Congo, boosting clinical trials

    The US has provided Ebola treatment for the outbreak in Congo, bringing clinical trials closer. The World Health Organization has begun a clinical trial of an Ebola vaccine in Congo to combat the ongoing outbreak. Over 4600 lives have been claimed since the outbreak began in May. African health experts urge immediate action over new Ebola cases in Kenya and Nigeria.

    Why it matters

    The Ebola outbreak in Congo has prompted a global response, with the World Health Organization leading efforts to contain the virus. The outbreak has spread to other countries in Africa, including Kenya and Nigeria. The clinical trial of the Ebola vaccine aims to evaluate its safety and efficacy against the Bundibugyo Ebola virus. The US has provided treatment to support the response efforts.

    What is confirmed

    • The World Health Organization has begun a clinical trial of an Ebola vaccine in the Democratic Republic of Congo.
    • Over 4600 lives have been claimed since the outbreak began in May.
    • African health experts have called for an immediate and coordinated response from pan-African authorities after new cases of the Bundibugyo Ebola virus emerged in Kenya and Nigeria.
    • The US has provided Ebola treatment for the outbreak in Congo.
    • Bundibugyo Ebola cases near 10,000 as Congo begins its first vaccine trial and the U.S. sets a Nov. 3 travel attestation.

    Still unconfirmed

    • IAVI awarded $36 million from BARDA for Bundibugyo virus vaccine development.

    What to watch next

    • The outcome of the clinical trial of the Ebola vaccine in Congo
    • The response of pan-African authorities to the new Ebola cases in Kenya and Nigeria
    • The impact of the US travel attestation on the spread of the virus
    Sources used for this update (13)
    1. medicalxpress.com β€” Medical Xpress: Health & Medical Research News
    2. www.yahoo.com β€” Yahoo
    3. www.dropsitenews.com β€” Netanyahu orders full lockdown of West Bank after shooting; Bombshell report on Kushner’s $2B slush fund; Brent crude hits $114 ....
    4. www.breitbart.com β€” Children Articles - Breitbart
    5. www.news-medical.net β€” African health experts urge immediate action over new Ebola cases
    6. www.natureworldnews.com β€” Bundibugyo Ebola Cases Near 10,000 as Congo Starts First Vaccine Trial and U.S. Adds a Travel Attestation - Nature World News
    7. jen.jiji.com β€” Chyngyz Aitmatov biopic to open International Film Festival in Istanbul
    8. inews.co.uk β€” The tax rise Healey isn’t talking about
    9. www.scidev.net β€” Ebola spread prompts call for coordinated African response
    10. www.arise.tv β€” Ihekweazu: Nigeria Must Complete 42-Day Monitoring Before Declaring Ebola-Free
    11. www.newsday.com β€” Inside the study for a remedy to fight Congo's deadliest Ebola outbreak
    12. www.pharmabiz.com β€” IAVI awarded $36 million from BARDA for Bundibugyo virus vaccine development
    confidence 70%
  6. Ebola vaccine trial starts in DR Congo

    The World Health Organization has begun a clinical trial of an Ebola vaccine in the Democratic Republic of Congo to combat the ongoing outbreak. The trial aims to evaluate the safety and efficacy of multiple vaccines against the Bundibugyo Ebola virus. Over 4,600 lives have been claimed since the outbreak began in May. The US has provided Ebola treatment for the outbreak, bringing clinical trials closer.

    Why it matters

    The Ebola outbreak in the Democratic Republic of Congo has caused significant concern due to its high mortality rate and the lack of an approved vaccine for the rare Bundibugyo strain. The World Health Organization has been working to start clinical trials of a vaccine, and the US has provided support by offering Ebola treatment. The outbreak has spread fear and concern across the region, prompting neighboring countries to increase surveillance and screening measures.

    What is confirmed

    • The first clinical trial of an Ebola vaccine in the outbreak gripping the Democratic Republic of Congo began on Friday, according to the head of the World Health Organization.
    • The US has provided Ebola treatment for the ongoing outbreak in the Democratic Republic of Congo, bringing clinical trials closer.
    • The outbreak has claimed over 4,600 lives since it began in May.
    • The trial aims to evaluate the safety and efficacy of multiple vaccines against the Bundibugyo Ebola virus.

    What to watch next

    • The outcome of the vaccine trial
    • The spread of the outbreak to neighboring countries
    • The effectiveness of the vaccines being tested
    Sources used for this update (7)
    1. www.thisdaylive.com β€” Ebola: FG Tightens Surveillance, Screening, Infected Woman Identified as Swiss Diplomat’s Wife – THISDAYLIVE
    2. jen.jiji.com β€” Almaty celebrates Republic Day with flag-raising near high-mountain Medeu rink
    3. jen.jiji.com β€” Dimash Qudaibergen sings original hits on DIMENSIONS Tour in DΓΌsseldorf
    4. medicalxpress.com β€” Ebola vaccine trial begins in DR Congo - Medical Xpress
    5. www.aljazeera.com β€” WHO announces start of Ebola vaccine clinical trial in DR Congo
    6. www.afp.com β€” Ebola vaccine trial begins in DR Congo | AFP.com
    7. news.cgtn.com β€” Major trial for new Ebola vaccine begins in DR Congo amid ...
    confidence 90%
  7. US provides Ebola treatment for Congo outbreak

    The US has provided Ebola treatment for the ongoing outbreak in the Democratic Republic of Congo, bringing clinical trials closer. The outbreak has caused over 4,000 deaths since it began five months ago. The World Health Organization expects the first vaccine clinical trial in the DRC to start by the end of October. No approved vaccine currently exists for the rare Bundibugyo strain.

    Why it matters

    The Ebola outbreak in the Democratic Republic of Congo is a significant public health concern, with a high death toll and risk of spread to neighboring countries. The World Health Organization and other global health authorities are working to contain the outbreak and develop effective treatments. The US provision of Ebola treatment is a key development in this effort.

    What is confirmed

    • The Ebola outbreak in the Democratic Republic of Congo has caused over 4,000 deaths.
    • The World Health Organization expects the first vaccine clinical trial in the DRC to start by the end of October.
    • Kenya has confirmed seven Ebola infections in people who had contact with a man who died after traveling from the Democratic Republic of Congo.

    What to watch next

    • The start of the first vaccine clinical trial in the DRC by the end of October
    • The effectiveness of the US-provided Ebola treatment
    • The spread of Ebola to other countries in the region
    Sources used for this update (3)
    1. www.bbc.com β€” BBC Home - Breaking News, World News, US News, Sports, Business...
    2. www.cidrap.umn.edu β€” Kenya reports more Ebola cases, all linked to initial patient | CIDRAP
    3. finance.yahoo.com β€” [Ad hoc announcement pursuant to Art. 53 LR] Roche continues strong momentum in the third quarter with sales growth of +7% at constant exchange rates (CER) and +…
    confidence 90%
  8. Bundibugyo Ebola Outbreak in DRC Claims Over 4,000 Deaths

    An Ebola outbreak in the Democratic Republic of Congo has caused more than 4,000 deaths five months after it began. While the US has provided treatment and the World Health Organization expects the first vaccine clinical trial in the DRC to start by the end of October, no approved vaccine currently exists for the rare Bundibugyo strain. Other efforts include clinical trials for a candidate vaccine against the same strain already underway in Uganda.

    Why it matters

    The Bundibugyo strain is a rare form of the virus. The lack of an approved vaccine increases the urgency of current clinical trials to prevent further fatalities.

    What is confirmed

    • The Ebola outbreak in the Democratic Republic of Congo has caused more than 4,000 deaths.
    • No approved vaccine currently exists for the Bundibugyo strain of Ebola.

    Still unconfirmed

    • Two Ebola cases were found in the same family in Kenya.
    • The first clinical trial of an Ebola vaccine in the DRC will begin by the end of October.
    • Uganda has launched clinical trials for a candidate vaccine against the Bundibugyo Ebola virus.

    What to watch next

    • Confirmation of the start of vaccine trials in the DRC
    • Updates on the death toll in the DRC
    • Verification of Ebola cases in Kenya
    Sources used for this update (3)
    1. transcripts.cnn.com β€” Zelenskyy Attends E.U. Summit As Ukraine-U.S. Ties Sour; Hurricane Trudy Strengthens To Category Three, Nears Mexico; Cornell Facu....
    2. www.contagionlive.com β€” Expert Interviews | Contagion Live
    3. www.rfi.fr β€” Ebola vaccine trials 'reason for hope' in DR Congo and beyond
    confidence 80%
  9. US provides Ebola treatment as Congo trials near

    The US has provided Ebola treatment for the outbreak in the Democratic Republic of Congo, bringing clinical trials closer. The World Health Organization says the first clinical trial of an Ebola vaccine in the DRC is expected to begin by the end of October. Uganda has already launched clinical trials for a candidate vaccine against the Bundibugyo Ebola virus.

    Why it matters

    The current epidemic in the DRC has rapidly become the second-largest Ebola outbreak on record. Health officials are racing to contain the outbreak and find effective treatments. The situation is critical, with multiple vaccines and treatments being tested.

    What is confirmed

    • The first clinical trial of an Ebola vaccine in the Democratic Republic of Congo is expected to begin by the end of October.
    • Uganda has launched clinical trials for a candidate vaccine against the Bundibugyo Ebola virus.
    • The current epidemic in the DRC has rapidly become the second-largest Ebola outbreak on record.

    Still unconfirmed

    • A Phase IIA Ebola Treatment Clinical Trial of NV-387 Oral Gummies is progressing well.

    What to watch next

    • The start of the Ebola vaccine clinical trial in the DRC by the end of October
    • The outcome of the Phase IIA Ebola Treatment Clinical Trial of NV-387 Oral Gummies
    Sources used for this update (4)
    1. nypost.com β€” New York Post – Breaking News, Top Headlines, Photos & Videos
    2. newsaf.cgtn.com β€” Ebola vaccine clinical trial to begin in DR Congo by end of ...
    3. medicalxpress.com β€” DR Congo Ebola vaccine trial to begin within weeks: WHO
    4. finance.yahoo.com β€” Phase II Clinical Trial of NV-387 Oral Gummies as Treatment ...
    confidence 90%
  10. Uganda Starts Ebola Vaccine Trials as DRC Outbreak Spreads

    Uganda has launched clinical trials for a candidate vaccine against the Bundibugyo Ebola virus, targeting the strain driving an escalating health emergency in the northeastern Democratic Republic of Congo. Phase Ib trials for the ChAdOx1 vaccine, developed by the University of Oxford, began in Uganda on October 6 following earlier Phase Ia trials in Britain. Meanwhile, another candidate vaccine developed by Moderna has secured ethical approval for Phase Ib trials in Uganda after starting Phase Ia trials in Canada. Health officials note that the current epidemic has rapidly become the second-largest Ebola outbreak on record.

    Why it matters

    The ongoing health crisis is caused by the Bundibugyo virus and is concentrated in the northeastern Democratic Republic of Congo. First reported in May 2026, the outbreak has expanded substantially faster than previous events according to the U.S. Centers for Disease Control and Prevention. The current strain has no approved vaccine or specific treatment, prompting international investments in vaccine and therapeutic trials alongside domestic preparedness measures and travel restrictions.

    What is confirmed

    • First reported in May 2026, the current Ebola disease outbreak is caused by the Bundibugyo virus and is concentrated in the northeastern Democratic Republic of Congo.
    • Phase Ib trials of the ChAdOx1 vaccine, developed by the University of Oxford, began in Uganda on October 6 after Phase Ia trials started in Britain in July.
    • A candidate vaccine developed by Moderna received ethical approval for Phase Ib trials in Uganda following Phase Ia trials in Canada in August.
    • The Bundibugyo Ebola strain currently has no approved vaccine or specific treatment.

    What to watch next

    • Results from the Phase Ib clinical trials of the ChAdOx1 and Moderna candidate vaccines in Uganda
    • Further updates from the U.S. Centers for Disease Control and Prevention regarding domestic preparedness and travel restrictions
    Sources used for this update (11)
    1. www.sandiegouniontribune.com β€” San Diego Union-Tribune
    2. www.disabled-world.com β€” Ebola Outbreak 2026: DR Congo, Uganda and Kenya Updates
    3. www.everycrsreport.com β€” 2026 Ebola Outbreak: Frequently Asked Questions - EveryCRSReport.com
    4. jen.jiji.com β€” Donald Trump announces β€˜energy ceasefire’ between Russia and Ukraine
    5. jen.jiji.com β€” Head of State underscores historic significance King of the Belgians’ visit to Kazakhstan
    6. www.the-star.co.ke β€” Uganda starts trials for vaccine against Kenya Ebola strain
    7. jen.jiji.com β€” Kazakhstan forecasts nearly 3.8 tn tenge in oil revenues for 2027
    8. jen.jiji.com β€” Kazakhstan’s Yussuf Ashrapov wins gold at U23 World Wrestling Championships in US
    9. www.europesays.com β€” New Ebola vaccine enters clinical trials in Africa as DR ...
    10. www.europesays.com β€” Ebola vaccine trials begin in Uganda as DR Congo toll tops ...
    11. sierraleonews.com β€” DRC Ebola outbreak passes 9,000 cases, 4,000 deaths
    confidence 95%
  11. DR Congo Ebola Toll Exceeds 4,200 Deaths As Prevention Trials Advance

    The Ebola outbreak in the Democratic Republic of the Congo has reached 8,728 total cases, including 4,205 deaths, according to the National Institute of Public Health. In response to the escalating crisis, clinical trials for the experimental antiviral drug obeldesivir have enrolled more than 250 participants who experienced high-risk exposure to the virus. Health authorities continue to manage patient care challenges as the virus spreads across the country. Meanwhile, international funding efforts have brought in over $2 billion in total pledges, and health workers are deploying 70,000 Ervebo vaccine doses.

    Why it matters

    The Democratic Republic of the Congo faces its deadliest Ebola outbreak, prompting an accelerated global response and large-scale clinical evaluations of post-exposure treatments. Jean Kaseya, Director-General of the Africa Centres for Disease Control and Prevention, warned of regional spillover risks after Kenya confirmed its first imported case of Bundibugyo Ebola virus disease on October 6 following a patient death in Nairobi. International donors gathered at a United States-hosted G20 ministerial to commit financial resources toward containing the outbreak.

    What is confirmed

    • The number of Ebola cases in the Democratic Republic of the Congo rose to 8,728, including 4,205 deaths.
    • Over 250 participants have enrolled in a trial for the experimental drug obeldesivir to test its effectiveness in preventing Ebola transmission.
    • Kenya confirmed its first imported case of Bundibugyo Ebola virus disease on October 6.

    What to watch next

    • Results from the ongoing obeldesivir clinical trials regarding its effectiveness in preventing Ebola symptoms.
    • Further updates from the Africa Centres for Disease Control and Prevention on regional spread to neighboring countries.
    Sources used for this update (8)
    1. www.state.gov β€” Press Releases - United States Department of State
    2. mainichi.jp β€” Inside the study for a remedy to fight Congo's deadliest Ebola outbreak - The Mainichi
    3. jen.jiji.com β€” Ebola cases in DR Congo reach 8,728, deaths exceed 4,200
    4. jen.jiji.com β€” Kazakhstan highlights Northern Aral recovery and return of rare species
    5. transcripts.cnn.com β€” W.H.O. Presses Russia for Information on Worker's Death; Trump Says He Will Ask Putin About Lab Worker's ....
    6. www.healthandme.com β€” Can Obeldesivir Prevent Ebola Symptoms After Exposure? Drug ...
    7. www.okaynews.com β€” Congo Trial Tests Ebola Prevention Pill Among High-Risk Contacts
    8. www.nature.com β€” Towards broader-spectrum direct-acting antivirals against RNA viruses | Nature Reviews Microbiology
    confidence 100%
  12. Global Leaders Pledge Over $470M for DRC Ebola Outbreak

    Global leaders secured more than $470 million in new global commitments during a United States-hosted G20 Foreign Ministerial on September 30, 2026, to accelerate response efforts against the Ebola outbreak in the Democratic Republic of the Congo. This brings total international pledges past $2 billion since the outbreak was declared in May 2026. Meanwhile, more than 250 participants have enrolled in a drug trial aimed at preventing Ebola transmission in the Central African country. Health workers are deploying 70,000 Ervebo vaccine doses as the outbreak spreads at an unprecedented rate, facing critical challenges in patient care.

    Why it matters

    The ongoing public health emergency in the Democratic Republic of the Congo represents the country's largest-ever and deadliest Ebola outbreak. International response efforts have scaled up significantly following earlier US pledges and high-level United Nations discussions. The coordination of G20 nations and international health bodies aims to address severe shortages in specialized care and rapid diagnosis.

    What is confirmed

    • The United States hosted a G20 Foreign Ministerial on September 30, 2026, and secured more than $470 million in new global commitments to accelerate response efforts against the Ebola Outbreak in DRC.
    • Total international pledges have surpassed $2 billion since the outbreak was declared in May 2026.
    • More than 250 participants have been enrolled in a trial for a drug that could stop them from contracting Ebola in Congo.

    Still unconfirmed

    • Non-G20 donor governments including Poland, Ireland, the Netherlands, Norway, Singapore, Qatar, and the United Arab Emirates attended the G20 Foreign Ministerial.

    What to watch next

    • Deployment and administration results of the 70,000 Ervebo vaccine doses in DR Congo
    • Progress and findings from the drug trial enrolling over 250 participants to prevent Ebola contraction
    Sources used for this update (16)
    1. www.cdc.gov β€” Ebola Outbreak: Current Situation | Ebola | CDC
    2. www.usbank.com β€” Personal Banking, Credit Cards, Loans & Investing | U.S. Bank
    3. en.wikipedia.org β€” List of states and territories of the United States - Wikipedia
    4. www.usa.gov β€” The U.S. and its government - USAGov
    5. simple.wikipedia.org β€” United States - Simple English Wikipedia, the free encyclopedia
    6. gardnermagazine.com β€” Weekly Briefing – Gardner Magazine – Gardner News Magazine: Local News & Articles in Gardner MA
    7. en.wikipedia.org β€” United States - Wikipedia
    8. www.nyas.org β€” Pandemic Promises Meet the Second-Largest Ebola Outbreak on Record - NYAS
    9. www.topafricanews.com β€” Global Leaders Pledge $470 Million to End Ebola Outbreak in ...
    10. news.un.org β€” DRC: Early access to care and oxygen decisive for Ebola ...
    11. en.parapolitika.gr β€” Ebola in Congo: 70,000 Ervebo vaccine doses deployed amid ...
    12. www.worldatlas.com β€” United States Map - World Atlas
    confidence 100%
  13. US provides Ebola treatment for outbreak in Congo, bringing trials closer

    The US has pledged $267 million in additional Ebola assistance for the Democratic Republic of Congo. The Ebola outbreak has claimed 3,901 lives out of 8,000 confirmed cases. The US support includes treatment units and expanded surveillance. The World Health Organization is calling for accelerated diagnosis, faster referrals, and specialized care to protect high-risk groups, particularly children under five years old.

    Why it matters

    The Ebola outbreak in the Democratic Republic of Congo continues to pose a significant health risk. The World Health Organization has emphasized the need for pediatric-specific interventions to reduce mortality rates among children. The US support aims to bolster the response efforts and bring clinical trials of Ebola treatments closer to reality.

    What is confirmed

    • The number of confirmed Ebola cases in the Democratic Republic of Congo has surpassed 8,000.
    • 3,901 people have died in the current Ebola outbreak in the Democratic Republic of Congo.
    • The US has pledged an additional $267 million for life-saving assistance against Ebola in Congo.
    • Children under five years old are experiencing a disproportionate number of deaths during the Bundibugyo virus outbreak in the Democratic Republic of Congo.

    What to watch next

    • Further international commitments to support Ebola response efforts
    • Progress in clinical trials of Ebola treatments
    • Development of pediatric-specific interventions to reduce mortality rates among children
    Sources used for this update (7)
    1. jen.jiji.com β€” Nor’easter threatens US East Coast as Tropical Storm Nolo nears Hawaii
    2. jen.jiji.com β€” Kazakhstan’s Kholmogorov takes 2026 Asian Games canoe sprint bronze
    3. www.breitbart.com β€” vaccines Articles - Breitbart
    4. www.africanews.com β€” Ebola cases in DR Congo cross 8,000 as EU, US pledge further ...
    5. globebanner.com β€” United States announces $267 million in additional Ebola ...
    6. www.cdc.gov β€” Notes from the Field: The First 100 Days of Five Ebola ...
    7. cmsapi.theepochtimes.com β€” US Pledges $267 Million More in Ebola Aid to Congo
    confidence 100%
  14. WHO warns children under five are most vulnerable in DRC Ebola outbreak

    Children under five years old are experiencing a disproportionate number of deaths during the Bundibugyo virus outbreak in the Democratic Republic of Congo. The World Health Organization is calling for accelerated diagnosis, faster referrals, and the implementation of specialized care to protect this high-risk group. While previous reports focused on US treatment provisions and trial progress, current warnings emphasize the critical need for pediatric-specific interventions to reduce mortality rates among the youngest victims of the outbreak.

    Why it matters

    The Bundibugyo virus is a species of Ebola that causes severe hemorrhagic fever. Rapid identification and specialized medical support are essential to prevent widespread fatalities in vulnerable populations.

    Still unconfirmed

    • Children under five are bearing a disproportionate share of deaths in the DRC's Bundibugyo virus outbreak

    What to watch next

    • WHO reports on the impact of faster diagnosis and specialized care for children
    Sources used for this update (5)
    1. jen.jiji.com β€” M5.4 earthquake strikes southeastern TΓΌrkiye
    2. jen.jiji.com β€” How Astana Airport is winning battle against bird strikes
    3. www.standardmedia.co.ke β€” Ebola Watch: WHO warns children under five face higher risk in DRC Ebola outbreak
    4. www.devdiscourse.com β€” Reuters Health News Summary
    5. eastleighvoice.co.ke β€” Nearly 1 in 6 children on weight-loss injections developed nutritional problems- study
    confidence 70%
  15. UK Scientists Identify Genetic Changes in Kent Meningitis Outbreak

    British researchers have identified genetic changes behind a severe meningococcal disease outbreak in Kent that struck 21 people in a single week. Scientists from the UK Health Security Agency, the University of Oxford, and academic partners sequenced bacteria from the March outbreak linked to a Canterbury nightclub. Research presented at the UKHSA Conference 2026 shows the strain acquired genetic material from less harmful throat bacteria via horizontal gene transfer. The cluster required hospital treatment for all diagnosed individuals, nine intensive care admissions, and resulted in two deaths.

    Why it matters

    The investigation into the Kent outbreak highlights the speed of genomic sequencing during public health crises, as researchers mapped the bacteria days after the initial case. Meningococcal disease remains a severe health threat, requiring rapid identification of genetic shifts that alter virulence. This genetic analysis contributes to ongoing global discussions on health security and pandemic preparedness featured at international forums.

    What is confirmed

    • Scientists from the UK Health Security Agency, the University of Oxford and academic partners identified genetic changes behind a meningococcal disease outbreak in Kent.
    • The outbreak was linked to a single nightclub in Canterbury over one weekend in March and resulted in 21 diagnoses within one week.
    • All 21 patients required hospital treatment, nine were admitted to intensive care and two died.
    • UKHSA scientists sequenced the outbreak bacteria within days of the first case and compared them with tens of thousands of meningococcal genomes.
    • Research presented at the UKHSA Conference 2026 found the outbreak strain acquired genetic material from less harmful bacteria naturally found in human throats through horizontal gene transfer.

    What to watch next

    • Further peer-reviewed publication of the preprint research presented at the UKHSA Conference 2026
    • Additional findings on how horizontal gene transfer impacts future meningococcal vaccine development
    Sources used for this update (3)
    1. jen.jiji.com β€” Scientists reveal genetic changes behind severe Kent meningitis outbreak
    2. foreignpolicy.com β€” Health Forum @ UNGA81
    3. jen.jiji.com β€” Tokayev nominates Yerlan Koshanov to head Khalyk Kenesi
    confidence 100%
  16. Vaccine tests launch in Democratic Republic of Congo Ebola outbreak zone

    Health workers launched a test vaccination program on Saturday in areas of the Democratic Republic of Congo most affected by the current Ebola outbreak. This follows previous medical interventions including the distribution of 16,000 Ervebo vaccine doses from Merck and treatment support provided by the United States. The effort aims to curb a crisis that has seen confirmed cases exceed 6,100 and deaths surpass 3,000, with a crude fatality rate of 48%.

    Why it matters

    The outbreak continues to expand across the region. NanoViricides, Inc. is scheduled to begin clinical trials for NV-387, an oral drug designed to slow viral spread. These combined efforts target a high mortality rate in a volatile health environment.

    What is confirmed

    • Total confirmed Ebola cases in the Democratic Republic of Congo have exceeded 6,100.
    • Deaths from the outbreak have surpassed 3,000.
    • The crude fatality rate for the current outbreak is 48%.
    • Merck previously distributed 16,000 doses of the Ervebo vaccine.

    Still unconfirmed

    • NanoViricides, Inc. will start clinical trials for the oral drug NV-387 next week.

    What to watch next

    • Results from the Saturday test vaccination program
    • Commencement of NV-387 clinical trials
    • Updated fatality and case counts from the DRC health ministry
    Sources used for this update (9)
    1. jen.jiji.com β€” European Commission proposes EU KIDS Act to strengthen online safety of children
    2. jen.jiji.com β€” The CSR and Social Innovation Exhibition returns to Milan from 6 to 8 October
    3. jen.jiji.com β€” Heat dome brings record heat to south-central US in mid-September
    4. jen.jiji.com β€” Nepal flood death toll reaches 1,410, 6,145 still missing
    5. jen.jiji.com β€” We must work for improving our citizens' social well-being, not image β€” Tokayev
    6. jen.jiji.com β€” Tokayev tours Mynzhyldyk alley and GreenLine park in Astana
    7. jen.jiji.com β€” Egyptian archeologists unearth rare tombs, Roman camp in Nile Delta
    8. jen.jiji.com β€” Kazakhstan women beat Germany at FIDE Chess Olympiad
    9. medicalxpress.com β€” Ebola vaccine being tested in DR Congo outbreak zone
    confidence 90%
  17. NanoViricides to begin Ebola oral drug trials in DR Congo next week

    NanoViricides, Inc. will start clinical trials for the oral drug NV-387 next week to combat the expanding Ebola outbreak in the Democratic Republic of Congo. The initiative aims to lower the 48% crude fatality rate and slow the spread of the virus. This follows previous efforts including the distribution of 16,000 Ervebo vaccine doses from Merck and treatment support from the United States. The outbreak continues to expand, with total confirmed cases exceeding 6,100 and deaths surpassing 3,000.

    Why it matters

    The virus is spreading faster than current tracking and containment efforts can manage. The World Health Organization previously scheduled trials for three potential vaccines for this specific strain to begin by October or November.

    What is confirmed

    • NanoViricides, Inc. will start clinical trials for the oral drug NV-387 next week.
    • The Ebola outbreak in the Democratic Republic of Congo has a 48% crude fatality rate.
    • Confirmed Ebola cases have exceeded 6,100 with more than 3,000 deaths.
    • Merck distributed over 16,000 Ervebo vaccine doses to address the outbreak.

    What to watch next

    • Results from the NV-387 clinical trials
    • Start of the three WHO vaccine trials in October or November
    • Official updates on the peak of the virus spread
    Sources used for this update (10)
    1. jen.jiji.com β€” Kazakhstan and U.S. discuss ways to strengthen enhanced strategic partnership
    2. jen.jiji.com β€” Death toll from Nepal-China flash floods climbs to 1,420, at least 5,649 missing
    3. jen.jiji.com β€” Kazakhstan, Czech Republic join efforts in water infrastructure modernization
    4. jen.jiji.com β€” US Open, today Zverev-Khachanov: schedule, head-to-head and where to watch it on TV
    5. jen.jiji.com β€” Axios: Top secret meeting in Germany between US, Israel, and Arab commanders
    6. jen.jiji.com β€” Center-left poll, Conte beats Schlein in primaries
    7. www.usatoday.com β€” Clinical Trial of the Oral Drug NV-387 to Treat Ebola to Start Next Week, Hoping to Reduce Fatalities and Spread, As the Largest Ebola Outbreak is Expanding in DR Congo with 48 ...
    8. jen.jiji.com β€” Kazakhstan plans fourth oil refinery by 2033
    9. jen.jiji.com β€” Kazakhstan’s recoverable oil reserves estimated at 4.4 billion tons
    10. www.aljazeera.com β€” Ebola fight in DRC β€˜far from over,’ warns WHO chief
    confidence 100%
  18. Ebola outbreak in eastern Congo outpaces containment efforts

    The Ebola outbreak in eastern Congo continues to spread faster than tracking and containment efforts can manage. The virus has likely not yet peaked, despite previous interventions including the distribution of over 16,000 Ervebo vaccine doses from Merck and treatment support from the United States. The World Health Organization has scheduled trials for three potential vaccines targeting this specific strain to begin by October or November. Total confirmed cases have exceeded 6,100, with more than 3,000 deaths reported.

    Why it matters

    Congo authorities are attempting to mitigate what is described as the fastest-growing outbreak in history. The situation remains critical as the speed of transmission exceeds the current capacity to isolate cases.

    What is confirmed

    • The Ebola outbreak in the Democratic Republic of Congo has killed more than 3,000 people.
    • Confirmed Ebola cases in Congo now exceed 6,100.
    • The World Health Organization scheduled trials for three potential vaccines for this strain to begin by October or November.
    • Over 16,000 Ervebo vaccine doses from Merck were distributed to slow the spread.

    Still unconfirmed

    • The Ebola virus in eastern Congo has likely not yet peaked.
    • The outbreak is spreading faster than efforts to track and contain it.

    What to watch next

    • The start of the three vaccine trials in October or November
    • Updated case and death tolls from the World Health Organization
    Sources used for this update (15)
    1. apnews.com β€” 5 challenges Congo faces in containing its fast-moving Ebola outbreak
    2. jen.jiji.com β€” Kazakhstan to create interactive map with history of geographic names
    3. jen.jiji.com β€” Kyrgyzstan to introduce mandatory tourist insurance
    4. jen.jiji.com β€” Tokayev signs decree defining powers of Kazakhstan’s Vice President
    5. jen.jiji.com β€” 35 Kazakh companies join China’s grain trading platform
    6. jen.jiji.com β€” Almaty oncology center introduces robotic pharmacy system
    7. jen.jiji.com β€” New exit and entry rules to come into force in China
    8. jen.jiji.com β€” Bishkek Arena stadium in Kyrgyzstan costs USD 386 million
    9. jen.jiji.com β€” Kazakhstan and Kyrgyzstan reaffirm commitment to allied relations
    10. medicalxpress.com β€” DRC's Ebola outbreak has the potential to become a global pandemic. How to make sure it doesn't
    11. jen.jiji.com β€” Almaty-London flight diverted to Frankfurt amid Heathrow closure
    12. www.usatoday.com β€” Ebola Oral Drug Trial NV-387 Registered in DRC for Outbreak
    confidence 90%
  19. Congo Ebola deaths exceed 3,000 as WHO targets vaccine trials for October

    The Ebola outbreak in the Democratic Republic of Congo has killed more than 3,000 people, with confirmed cases now exceeding 6,100. The World Health Organization announced Wednesday that trials for three potential vaccines targeting this specific strain are scheduled to begin by October or November. This follows previous efforts to slow the spread through the distribution of over 16,000 Ervebo vaccine doses from Merck and treatment support provided by the United States. Congo authorities previously began vaccinating citizens to mitigate the fastest-growing outbreak in history.

    Why it matters

    The scale of this outbreak is unprecedented, requiring international medical intervention to prevent further escalation. The transition to clinical trials for new vaccines indicates a shift toward finding a long-term solution for this specific strain. Ongoing government data tracking is essential for determining the efficacy of these medical interventions.

    What is confirmed

    • Congo's Ebola outbreak has killed more than 3,000 people.
    • Confirmed Ebola cases in Congo have exceeded 6,100.
    • The World Health Organization stated trials for three potential vaccines should begin by October or November.

    What to watch next

    • The official start date for the three vaccine trials in October or November
    • Updated case and death tolls from the Congo government
    Sources used for this update (6)
    1. jen.jiji.com β€” Egypt bus crash leaves 16 dead, 28 injured
    2. jen.jiji.com β€” Herd of Siberian ibex spotted in Ile-Alatau National Park
    3. apnews.com β€” Congo’s Ebola outbreak shows no signs of slowing as deaths top 3,000
    4. www.news9live.com β€” News headlines September 2, 2026: Nearly 12,000 rescued, 3,916 remain uncontactable: Nepal PM Shah
    5. jen.jiji.com β€” Kazakhstan moves ahead with construction of first nuclear power plant
    6. medicalxpress.com β€” DR Congo Ebola vaccine trials to begin by November: WHO
    confidence 100%
  20. Congo Ebola Outbreak Surpasses 6,000 Cases

    Congo authorities report that the fastest-growing Ebola outbreak in history has now exceeded 6,000 confirmed cases and 2,911 deaths. In response to the escalation, Congo began vaccinating citizens on Thursday to slow the spread of the disease. This effort follows previous shipments of over 16,000 doses of the Ervebo vaccine from Merck and treatment support provided by the United States.

    Why it matters

    The outbreak has already affected 60 health zones. It is currently the deadliest Ebola outbreak on record. Health officials are utilizing vaccinations and international aid to contain the virus.

    What is confirmed

    • Congo authorities report more than 6,000 confirmed Ebola cases and 2,911 deaths.
    • Congo began vaccinating people against Ebola on Thursday.
    • The current Ebola outbreak is the fastest-growing in history.

    What to watch next

    • Updates on vaccination coverage rates across the 60 affected health zones
    • Reports on the efficacy of the current vaccination campaign in reducing new cases
    Sources used for this update (6)
    1. jen.jiji.com β€” Kazakh equestrian claims silver at international tournament in Poland
    2. medicalxpress.com β€” Congo begins vaccinations to fight the fastest-growing Ebola outbreak in history
    3. jen.jiji.com β€” ADB approves $5 million emergency grant for Nepal flood relief
    4. apnews.com β€” Congo authorities report more than 6,000 confirmed Ebola cases and nearly 3,000 deaths
    5. jen.jiji.com β€” Kazakhstan, Saudi Arabia deepen transport and logistics cooperation
    6. jen.jiji.com β€” Kazinform News Agency and Albanian Telegraphic Agency open new communication channel
    confidence 100%
  21. Congo's Ebola outbreak spreads as US provides treatment and vaccine doses

    The Ebola outbreak in Congo has infected nearly 4,000 people and killed over 2,000, making it the deadliest outbreak in history. The US is providing Ebola treatment, and Congo has received over 16,000 doses of Merck's Ervebo vaccine. The outbreak has spread to 60 health zones, with over 300 deaths reported in the past week alone.

    Why it matters

    The Ebola outbreak in Congo is the fastest-growing in history, with a high number of cases and deaths reported in a short period. The disease has spread to multiple health zones, posing a significant challenge to health authorities. The international community, including the US, is providing support to combat the outbreak.

    What is confirmed

    • Congo has received more than 16,000 doses of the Ervebo vaccine.
    • The Ebola outbreak in Congo has infected nearly 4,000 people and killed over 2,000.
    • More than 300 people have died of Ebola in eastern Congo in the past week.
    • The outbreak has spread to 60 health zones in eastern Congo.

    What to watch next

    • Further spread of the outbreak to new health zones
    • Effectiveness of the US-provided Ebola treatment and Merck's Ervebo vaccine
    • Congo government's response to the outbreak and containment efforts
    Sources used for this update (8)
    1. abcnews.com β€” Congo receives more than 16,000 doses of Ebola vaccine amid unprecedented outbreak
    2. apnews.com β€” Congo’s Ebola outbreak records one of its highest weekly death tolls yet
    3. jen.jiji.com β€” 232 Kazakhstanis awarded Bolashak international scholarships
    4. san.com β€” A cancer vaccine breakthrough, medical AI faces a reality check and recalls pile up
    5. jen.jiji.com β€” Tokayev instructs drafting bills on AI, digital assets, and migration policy
    6. jen.jiji.com β€” Bronze Age settlement unearthed in N Kazakhstan
    7. apnews.com β€” Ebola outbreak in eastern Congo spreads to 2 new health zones with a total of 60 areas now affected
    8. apnews.com β€” Congo begins vaccinations to fight the fastest-growing Ebola outbreak in history
    confidence 100%
  22. US provides Ebola treatment for Congo outbreak

    The US is providing Ebola treatment for the outbreak in Congo, which is on track to surpass the deadliest outbreak in history. Congo will receive 70,000 doses of Merck's Ervebo Ebola vaccine, effective in past outbreaks. The outbreak has infected and killed more people at a greater speed than any other Ebola outbreak in history, with cases approaching 4,000 and at least 2,000 deaths.

    Why it matters

    The World Health Organization has warned that the crisis is on track to surpass the deadliest outbreak in history. The WHO chief has arrived in Congo to support ramped-up containment measures. Health officials are advancing talks to launch clinical trials for vaccines, starting with Merck's Ervebo and potentially including other candidates targeting the Bundibugyo species of the virus.

    What is confirmed

    • The Ebola outbreak in Congo has infected and killed more people at a greater speed than any other Ebola outbreak in history.
    • Congo will receive 70,000 doses of Merck's Ervebo Ebola vaccine, which was effective in past outbreaks.
    • The WHO said early laboratory and animal data suggest Ervebo may provide some protection against the Bundibugyo virus.

    What to watch next

    • The effectiveness of Ervebo against the Bundibugyo virus.
    • The launch of clinical trials for vaccines.
    • The impact of the outbreak on surrounding countries.
    Sources used for this update (4)
    1. www.pbs.org β€” Congo to receive 70,000 doses of Ervebo Ebola vaccine, which was effective in past outbreaks
    2. www.inquirer.com β€” Congo to receive 70,000 doses of Ervebo Ebola vaccine, which has been effective in past outbreaks
    3. www.fbcnews.com.fj β€” Warning on addiction help amid funding uncertainty
    4. apnews.com β€” Here’s data that shows Congo’s Ebola outbreak is on track to surpass history’s largest
    confidence 90%
  23. Congo Ebola deaths top 2,000 as WHO warns of record-breaking outbreak

    Congo is facing the fastest-spreading Ebola outbreak on record, with at least 2,000 deaths and cases approaching 4,000. The World Health Organization warns the crisis is on track to surpass the deadliest outbreak in history. In response, the WHO chief has arrived in Congo to support ramped-up containment measures. Health officials are advancing talks to launch clinical trials for vaccines, starting with Merck's Ervebo and potentially including other candidates targeting the Bundibugyo species of the virus.

    Why it matters

    The current outbreak follows a period of rapid growth that previously saw over 3,400 cases. While Uganda recently declared itself free of the disease, the Congo situation is escalating in scale and lethality. The shift toward clinical trials indicates a move toward species-specific medical interventions.

    What is confirmed

    • At least 2,000 people have died among confirmed Ebola cases in Congo.
    • The current Ebola outbreak in Congo is the fastest-spreading on record.
    • The head of the World Health Organization has arrived in Congo to support response measures.

    Still unconfirmed

    • Other vaccines targeting the Bundibugyo species of Ebola could be added to trials.

    What to watch next

    • Updated case and death counts from the Congo government.
    Sources used for this update (5)
    1. consent.yahoo.com β€” Treatment trials for Ebola strain behind Congo outbreak show promise, WHO says
    2. apnews.com β€” WHO chief arrives in Congo to support Ebola response as cases near 4,000
    3. www.cbsnews.com β€” Congo Ebola death toll tops 2,000 as outbreak becomes fastest spreading on record
    4. www.latimes.com β€” WHO says Congo’s Ebola outbreak is on track to eclipse the deadliest one in history
    5. www.statnews.com β€” Talks on launch of clinical trial of Ebola vaccine in DRC advance, WHO says
    confidence 90%
  24. Congo Ebola death toll exceeds 1,500 as Uganda declares virus free

    Congo continues to battle a rapid Ebola outbreak with over 3,400 recorded cases. Uganda has officially declared itself free of the disease following the discharge of its final patient. The Africa Centers for Disease Control and Prevention attributes a recent spike in numbers to a backlog of records.

    What's confirmed:

    • Uganda declared itself free of Ebola on Tuesday.
    • The last Ebola patient in Uganda was discharged in mid-June.
    • Congo has recorded 3,442 cases and 1,521 deaths as of Tuesday.
    Sources used for this update (2)
    1. Uganda declares itself Ebola-free as Congo continues to struggle with the outbreak
    2. Congo says the death toll in fastest-growing Ebola outbreak has passed 1,500
    confidence 100%
  25. Ebola cases in eastern Congo surpass 3,200

    The Ebola outbreak in eastern Congo has exceeded 3,200 cases. This surge nearly matches the totals from the 2018-2020 outbreak in just 10 weeks. Uganda has declared itself free of the disease.

    What's confirmed:

    • The Ebola outbreak in eastern Congo has surpassed 3,200 cases.
    • The outbreak in Congo is nearing record-high case numbers.

    Still unconfirmed:

    • The current outbreak has nearly matched the 2018-2020 outbreak in 10 weeks.
    • Uganda is Ebola free.
    Sources used for this update (2)
    1. Ebola cases in Congo top 3,200, nearing record of the country’s worst outbreak
    2. Uganda Says It’s Ebola Free As Cases In Congo Near Record Numbers
    confidence 90%
πŸ“Š

Community Sentiment: How do you assess this situation?

Voice your perspective Β· Real-time aggregated sentiment from the Live Feeds community